Outcome in relation to discussion of COVID-19 oral treatments – November 2022 PBAC meeting

PBAC

24 November 2022 - A PBAC outcome in relation to discussion of COVID-19 oral treatments at the November 2022 meeting has been published.

At its November 2022 meeting, the PBAC  considered several aspects of the PBS listings of the COVID19 oral ant-ivirals, molnupiravir (Lagevrio) and nirmatrelvir and ritonavir (Paxlovid).

Read PBS News

Michael Wonder

Posted by:

Michael Wonder